BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23729316)

  • 21. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway.
    Wang S; Huang X; Li Y; Lao H; Zhang Y; Dong H; Xu W; Li JL; Li M
    Hepatology; 2011 Jun; 53(6):1932-42. PubMed ID: 21391225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
    Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation-increased CXCL10 is associated with earlier recurrence of hepatocellular carcinoma by promoting stemness.
    Ouyang Y; Liu K; Hao M; Zheng R; Zhang C; Wu Y; Zhang X; Li N; Zheng J; Chen D
    Tumour Biol; 2016 Mar; 37(3):3697-704. PubMed ID: 26462839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation.
    Jia G; Li F; Tong R; Liu Y; Zuo M; Ma L; Ji X
    Med Oncol; 2020 Nov; 37(12):117. PubMed ID: 33215351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion.
    Tong Y; Yang H; Xu X; Ruan J; Liang M; Wu J; Luo B
    Cancer Sci; 2017 Apr; 108(4):753-762. PubMed ID: 28182306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.
    Kong J; Kong L; Kong J; Ke S; Gao J; Ding X; Zheng L; Sun H; Sun W
    J Transl Med; 2012 Nov; 10():230. PubMed ID: 23171368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
    Zeng J; Cai X; Hao X; Huang F; He Z; Sun H; Lu Y; Lei J; Zeng W; Liu Y; Luo R
    Int J Hyperthermia; 2018 Sep; 34(6):802-811. PubMed ID: 29295626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
    Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
    Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer.
    Chen JS; Su IJ; Leu YW; Young KC; Sun HS
    Int J Cancer; 2012 Mar; 130(6):1302-13. PubMed ID: 21469146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition.
    He Q; Li H; Meng F; Sun X; Feng X; Chen J; Li L; Liu J
    Oxid Med Cell Longev; 2018; 2018():5287971. PubMed ID: 29861830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidation of heat shock protein 60 and protein disulfide isomerase activates ERK and migration of human hepatocellular carcinoma HepG2.
    Lin CY; Hu CT; Cheng CC; Lee MC; Pan SM; Lin TY; Wu WS
    Oncotarget; 2016 Mar; 7(10):11067-82. PubMed ID: 26840563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.
    Xu J; Li X; Yang H; Chang R; Kong C; Yang L
    Cancer; 2013 Jun; 119(12):2247-57. PubMed ID: 23564492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
    Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
    Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.